ArticleFood quality and preference2026
U.S. Consumer Preferences for FDA Healthy vs. Generic Healthy Food Labels: The Influence of Trust.
Article in Food quality and preference, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Healthy food labels can help consumers make more informed purchasing decisions. In 2024, the U.S. FDA updated the definition of "healthy" and, for the first time, proposed a new "FDA healthy" label for food packages. The impact of such a healthy label in altering food choice and the influence of measurable trust have not been evaluated. We performed a randomized controlled trial using Real Choice Experiments to identify the impact of (1) FDA-endorsed and (2) generic healthy labels on consumers' preferences for snack foods, and the influence of different aspects of consumer trust on the effect of labels. We also estimate consumers' willingness to pay for foods with these labels. The intervention was conducted in-person among 276 shoppers at stores located in lower-income communities. We found that consumers selected healthier snack options approximately 60% of the time and exhibited an additional preference for healthier snacks when they bore a healthy label (approximately 67%). Overall, little difference was observed between FDA and generic healthy labels. However, trust in the government moderated the effect of the FDA label on consumer purchasing decisions. Consumers are willing to pay $0.59 more for a healthy product with an FDA-endorsed healthy label compared to a product with no label. These results have implications for regulatory bodies' measures to shift consumers' food choices and ultimately benefit their health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.